Hostname: page-component-7b7567c8c-mnklg Total loading time: 0 Render date: 2026-11-13T01:46:28.817Z Has data issue: false hasContentIssue false

The structural basis of function in Cys-loop receptors

Published online by Cambridge University Press:  20 September 2010

Andrew J. Thompson
Affiliation:
Department of Biochemistry, University of Cambridge, Building O, Downing Site, Cambridge CB2 1QW, UK
Henry A. Lester
Affiliation:
California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA
Sarah C. R. Lummis*
Affiliation:
Department of Biochemistry, University of Cambridge, Building O, Downing Site, Cambridge CB2 1QW, UK
*
*Author for correspondence: Sarah C. R. Lummis, Department of Biochemistry, University of Cambridge, Building O Downing Site, Cambridge CB2 1QW, UK. Tel.: 01223 333600; Fax: 01223 333345; Email:sl120@cam.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Cys-loop receptors are membrane-spanning neurotransmitter-gated ion channels that are responsible for fast excitatory and inhibitory transmission in the peripheral and central nervous systems. The best studied members of the Cys-loop family are nACh, 5-HT3, GABAA and glycine receptors. All these receptors share a common structure of five subunits, pseudo-symmetrically arranged to form a rosette with a central ion-conducting pore. Some are cation selective (e.g. nACh and 5-HT3) and some are anion selective (e.g. GABAA and glycine). Each receptor has an extracellular domain (ECD) that contains the ligand-binding sites, a transmembrane domain (TMD) that allows ions to pass across the membrane, and an intracellular domain (ICD) that plays a role in channel conductance and receptor modulation. Cys-loop receptors are the targets for many currently used clinically relevant drugs (e.g. benzodiazepines and anaesthetics). Understanding the molecular mechanisms of these receptors could therefore provide the catalyst for further development in this field, as well as promoting the development of experimental techniques for other areas of neuroscience.

In this review, we present our current understanding of Cys-loop receptor structure and function. The ECD has been extensively studied. Research in this area has been stimulated in recent years by the publication of high-resolution structures of nACh receptors and related proteins, which have permitted the creation of many Cys loop receptor homology models of this region. Here, using the 5-HT3 receptor as a typical member of the family, we describe how homology modelling and ligand docking can provide useful but not definitive information about ligand interactions. We briefly consider some of the many Cys-loop receptors modulators. We discuss the current understanding of the structure of the TMD, and how this links to the ECD to allow channel gating, and consider the roles of the ICD, whose structure is poorly understood. We also describe some of the current methods that are beginning to reveal the differences between different receptor states, and may ultimately show structural details of transitions between them.

Information

Type
Review Article
Copyright
Copyright © Cambridge University Press 2010
Figure 0

Fig. 1.Important functional components of the 5-HT3 receptor, a typical member of the Cys-loop family of LGICs. The structure shown is a 5-HT3 homology model based on a 4 Å-resolution structure of the nAChR (Miyazawa et al.2003; PDB ID: 2BG9). The 5-HT3 receptor, like the other members, consists of five subunits (1–5). The receptor is shown from above and from the side with two (red & blue) of the five subunits highlighted. Specific residues of interest are highlighted in yellow. The receptor is modular in nature and can be considered as having three main regions termed the ECD, TMD and ICD. The ECD contains the ligand-binding site that is formed by the convergence of six peptide loops located at the interface of two adjacent subunits (Noam et al.2008; Thompson & Lummis, 2006). Three rings of charged amino acids (extracellular, intermediate and cytoplasmic) are found in the pore lining α-helices of the TMD (Gunthorpe & Lummis, 2001; Thompson & Lummis, 2003), and a hydrophobic constriction in the centre of the channel acts as the channel gate (Panicker et al.2002).

Figure 1

Fig. 2.Alignment of human 5-HT3 receptor subunits. The binding loops (A–F) and transmembrane (M1–M4) regions are highlighted by horizontal lines above the text. Conserved residues are highlighted with a grey background. The human alternative long (5-HT3AL), truncated (5-HT3AT), Brain1 (5-HT3BR1) and Brain2 (5-HT3BR2) forms are shown. The boxes show the additional residues found in 5-HT3AL (32 amino acids) and 5-HT3D (12 amino acids) variants. Accession numbers for the alignment are as follows: 5-HT3A P46098, 5-HT3B O95264 and 5-HT3C Q6V706. 5-HT3D and 5HT3E were taken from Niesler et al. (2003). 5-HT3AL and 5-HT3AT were taken from Bruss et al. (2000). 5-HT3BR1 and 5-HT3BR2 were taken from Tzvetkov et al. (2007).

Figure 2

Fig. 3.AChBP, an analogous protein to the ECD of Cys-loop receptors. AChBP contains five subunits, but for clarity only two of these are shown. The binding loops and β-sheets are shown, the positions of which are taken from Brejc et al. (2001). The same binding loops and β-sheets are labelled in the linear amino-acid sequence below.

Figure 3

Table 1.Aromatic residues in the binding sites of different Cys-loop receptors. Residues that contribute to cation-π interactions are shown in bold. 1,3Beene et al. (2002), 2Xiu et al. (2009), 4Mu et al. (2003), 5Padgett et al. (2007), 6Lummis et al. (2005a), 7Pless et al. (2008). See Dougherty (2008) for further information. Note that loop D is in the complementary face, and residues from this face have not been found to form cation–π interactions to date

Figure 4

Fig. 4.An overlay of two 5-HT3 receptor homology models that were based on HEPES bound AChBP structures (PDB ID: 1I9B white and 1UX2 orange). Some residues that have been shown to be important for granisetron (a selective 5-HT3 antagonist) binding are highlighted and emphasize that some regions e.g. close to W195, have large differences in the orientation of their side chains. The relative positions of the models were compiled by Swiss-PdbViewer ‘magic fit’ using loop B as a reference point.

Figure 5

Fig. 5.A test for the accuracy of computational ligand docking. (A) Nicotine and carbamylcholine re-docked into their respective AChBP structures. (B) Nicotine docked into the carbamylcholine structure and vice versa. (C) Nicotine docked into two other AChBP structures. In each panel, the original ligand molecule is shown in grey and 10 docking solutions are shown in white; the ligands are clearly positioned on top of one another within the binding site.

Figure 6

Fig. 6.Examples of the eight main categories of docked poses found in the 320 homology models generated for this study. Categories were largely based on the proximity of granisetron atoms to W183, and the orientation of the azabicyclic and indazole rings. The number of docked poses that fell into each of these categories can be seen in Tables 2 and 3. In brief, the descriptions of these clusters are as follows: (A1) Indazole ring close to W183 and the azabicyclic ring orientated towards the membrane. (A2) Same as A1, but with the azabicyclic and indazole rings reversed. (B1) Indazole ring close to W183 and the azabicyclic ring orientated towards Y143 in loop E. (B2) Same as B1, but with the azabicyclic and indazole rings reversed. (C1) Carbonyl linker close to W183 and the azabicyclic ring orientated away from the membrane. (C2) Same as (C1), but with the indazole ring orientated away from the membrane. (D) Either the azabicyclic or indazole rings close to W183 and the opposite end of the ligand orientated towards loop C. (E) Granisetron lies horizontally across the back of loop C. (Other) A number of unique positions located throughout the ECD.

Figure 7

Table 2.Flexible ligand docking of granisetron into the 5-HT3 receptor-binding site produces docked clusters that can be categorized into one of eight groups (A1–E). Docking solutions that place granisetron outside the binding site are described as others. The data were created using the boat-chair configuration of granisetron docked into a series of 5-HT3 homology models that were generated from the 18 currently available PDB templates that show homology to Cys-loop receptors. The protein sequence of the murine 5-HT3 receptor (accession number: Q6J1J7) was co-aligned with each of the template sequences using FUGUE, which takes into account secondary structures (Shi et al.2001). Using Modeller 6v2, five homology models were generated from each PDB template (Sali & Blundell, 1993), and the best model selected using Ramachandran plot analysis. The protonated form of granisetron was constructed in Chem3D Ultra 7.0 (CambridgeSoft, Cambridge, UK) based on the crystal structure of a related indazole carboxamide (Cambridge Structural Database; reference code FIZXUH) and docked with GOLD v3.0 (The Cambridge Crystallographic Data Centre, Cambridge, UK), into a binding site that was defined as being within 20 Å of the α-carbon of W183. To dock ligands, 10 genetic algorithm runs were carried out for each homology model, with a population size of 50 and the maximum number of generations set to 27 000. For each homology model, the 10 docking solutions were categorized according to the ligand orientation, and the number of solutions in each category are shown (see Fig. 6 legend for descriptions)

Figure 8

Table 3.Rigid ligand docking of granisetron into the 5-HT3 receptor binding site produces docked clusters which can be categorized into one of five groups. Methods used can be found in the legend of Table 2

Figure 9

Fig. 7.AChBP crystal structures showing the orientations of cocaine (PDB ID: 2PGZ at 1·76 Å) and tropisetron (2WNC at 2·2 Å). The orientations are most similar to category E described in Fig. 6.

Figure 10

Fig. 8.Binding site substitutions that cause significant changes in the binding affinity of granisetron at the 5-HT3 receptor. Residues have been superimposed upon a homology model of the 5-HT3 receptor that was generated using 1I9B. The data were taken from Beene et al. (2004), Boess et al. (1997), Joshi et al. (2006), Price et al. (2008), Schreiter et al. (2003), Spier & Lummis (2000), Thompson et al. (2005, 2006b, 2008), Venkataraman et al. (2002a, b), Yan et al. (1999), Yan & White (2005) and Sullivan et al. (2006).

Figure 11

Fig. 9.Preferred orientations for 5-HT and granisetron docked into a homology model of the 5-HT3 receptor binding site. Both orientations provide the best fit for the experimental data. The ligands can potentially interact with W183, are influenced by a range of aromatic residues that are orientated with their π-rings normal to the ligand, and have critical hydrogen bonds interactions with E129. See text for more details.

Figure 12

Fig. 10.Comparisons of TMDs from open and closed receptors. Top panel: structures of nAChR (closed; Miyazawa et al.2003; PDB ID: 2BG9), ELIC (closed; Hilf & Dutzler, 2008; PDB ID: 2VL0) and GLIC (open; Bocquet et al.2007; PDB ID: 3EAM) are shown. Two (red and blue) of the five subunits are highlighted. M2 lines the central pore, and residues that face this water accessible surface are shown in Fig. 11. Lower panels: pore diameter as calculated by HOLE, with a 15 Å cut-off to find the ends of the pores (Smart et al.1993). Each tick on the vertical axis is 25 Å. The nAChR pore appears longer, because the structure also contains part of the ICD.

Figure 13

Fig. 11.M2 channel lining residues in different Cys-loop receptors. Pore-lining residues are shown next to the M2 α-helix (taken from the nAChR structure; PDB ID: 1oed). To allow for comparisons between M2 residues of different Cys-loop receptors, a prime (‘) notation is used: residues are assigned numbers according to their position relative to a charged M2 residue that is conserved in Cys-loop receptors. Residues that are accessible to modification are highlighted : 1Kaneez & White (2004), 2Reeves et al. (2001), 3Panicker et al. (2002), 4Akabas et al. (1994), 5Xu & Akabas (1996), 6Shan et al. (2002), 7Lynch et al. (2001) and 8Lobo et al. (2004). Accession numbers for the sequence alignment are: Mouse 5-HT3A, Q6J1J7; Electric Ray ACh α1, P02710; Human GABAA, α1 P14867; Human Gly α1, P23414.